[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.171.35. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 127
Citations 0
Comment & Response
September 2016

Critical Flaws in the Validation of the Instant Blood Pressure Smartphone App—A Letter From the App Developers

Author Affiliations
  • 1AuraLife, Newport Beach, California.
JAMA Intern Med. 2016;176(9):1410. doi:10.1001/jamainternmed.2016.4753

To the Editor In a recent issue of JAMA Internal Medicine, Dr Plante and colleagues reported on the accuracy of the Instant Blood Pressure (IBP) app.1 We identified misrepresentations and deficiencies in how the study and its analysis were conducted. Here we present our observations for consideration.

The authors failed to disclose that approximately 20% of their data were associated with reference blood pressures outside IBP’s supported measurement range. As published on the website2 (data not peer reviewed) and App Store description prior to the start of the authors’ data collection, IBP will not produce estimates outside of its supported range (systolic, 102-158 mm Hg; diastolic, 65-99 mm Hg). We believe the authors’ failure to disclose or mention IBP’s supported range misled readers.

First Page Preview View Large
First page PDF preview
First page PDF preview
×